GMP Storage Market Gains Momentum from Pharmaceutical Manufacturing Investments

The global GMP (Good Manufacturing Practice) storage market is a key segment within the broader cold chain logistics industry, which plays a crucial role in ensuring the integrity and safety of temperature-sensitive products, particularly within the pharmaceutical and biopharmaceutical sectors. As of 2021, the GMP storage market was valued at approximately US$ 5.7 billion, and it is projected to grow at a compound annual growth rate (CAGR) of 5.6% to reach a market value of US$ 10.2 billion by 2032. The sector is rapidly evolving, driven by an increasing demand for biologic drugs, vaccines, and biologically derived medicines, all of which require stringent storage conditions to maintain product quality and efficacy.

Download Your Free Sample & Explore Key Insights: https://www.persistencemarketresearch.com/samples/33113

Overview of the Market, Market Statistics, Key Growth Drivers, and Leading Segment

The GMP storage market is integral to the pharmaceutical supply chain, specifically for biologics, gene therapies, and vaccines, which require highly controlled environments. Temperature-controlled storage, typically through refrigerated and frozen facilities, is essential for maintaining the stability and effectiveness of these products. The market's strong growth is being fueled by a variety of factors, including advancements in biotechnology, the increasing approval of temperature-sensitive drugs by regulatory bodies like the U.S. FDA, and the rising demand for biologic drugs, especially post-pandemic.

By 2032, GMP storage services and products are expected to account for around 4.7% of the global cold chain logistics market, which was valued at approximately US$ 119.98 billion in 2021. With the biopharmaceutical sector booming, particularly in the U.S., China, and Germany, the demand for GMP storage services continues to rise. The U.S. holds a dominant position in the global market, primarily due to an increase in FDA-approved cold storage drugs, while Germany and China are also witnessing substantial growth driven by thriving biotechnology industries and strong government support for biopharmaceutical research and development.

Key Highlights from the Report:

• The GMP storage market was valued at US$ 5.7 billion in 2021.
• The market is expected to grow at a CAGR of 5.6% between 2022 and 2032.
• By 2032, the GMP storage market is projected to reach US$ 10.2 billion.
• North America holds the largest market share of GMP storage products and services.
• Biopharmaceutical companies represent the largest consumer of GMP storage services.
• Technological advancements are driving the growth of the GMP storage sector.

Market Segmentation

The GMP storage market is segmented based on product type, end-user industry, and application, all of which significantly influence the demand for these services.

Product Type: The GMP storage market is primarily divided into products and services. The product segment, which includes biomedical refrigerators, freezers, and controlled-rate freezers, held a significant market share of 83.1% in 2021. These products are crucial for maintaining the temperature requirements of biologics, vaccines, and other temperature-sensitive products.

End-User Industry: The biopharmaceutical sector is the largest end-user of GMP storage products and services, accounting for around 42.5% of the market share in 2021. Biopharmaceutical companies are increasingly outsourcing GMP storage services to streamline operations and adhere to strict regulatory standards. The rising production of biologics, cell-based therapies, and gene therapies has created a growing need for highly specialized storage solutions.

Application: Biologics held the largest share of the market, with a 38% market share in 2021. This category includes life-saving vaccines, blood plasma, and gene therapies that require refrigerated or cryogenic storage to maintain their effectiveness. The increase in demand for temperature-sensitive pharmaceuticals has created a robust demand for GMP storage facilities.

Geographical Segmentation: Geographically, North America, Europe, and East Asia represent the largest markets for GMP storage. North America, particularly the U.S., benefits from the strong presence of pharmaceutical companies and regulatory approvals for biologics. Europe's growth is bolstered by the presence of a robust biopharmaceutical industry, particularly in Germany, while China's market is expanding rapidly due to heavy government investments in biotechnology.

Get Custom Insights Designed for Your Business: https://www.persistencemarketresearch.com/request-customization/33113

Regional Insights

North America: The U.S. dominates the GMP storage market in North America, largely driven by the increasing approval of temperature-sensitive biologics by the FDA. With a rising number of cold storage drugs approved for use, such as the Pfizer-BioNTech COVID-19 vaccine, the demand for GMP storage in the U.S. is growing rapidly. The U.S. pharmaceutical market is robust, with continuous innovations and advancements in biotechnology, which have amplified the need for cold chain logistics.

Europe: Germany is the largest market for GMP storage in Europe, with a market share of around 29.7% in 2021. The country has one of the largest biopharmaceutical industries in the European Union, particularly in South Germany's BioPharma Cluster. This cluster is one of the world's most important centers for the development and manufacturing of biopharmaceuticals, thus increasing the need for cold chain storage to ensure compliance with stringent regulatory standards.

East Asia: China holds the largest market share in East Asia, accounting for approximately 49.4% of the region's GMP storage market. The Chinese government's significant investments in biotechnology and research and development are driving this growth. The establishment of biotech science parks and innovation hubs, such as the Shenzhen Institute of Synthetic Biology and Beijing's Genomics Institute, has fueled the demand for GMP storage facilities in the region.

Market Drivers

Several factors are contributing to the robust growth of the GMP storage market, including the following:

Increase in Temperature-Sensitive Drug Approvals: With the rise in the approval of temperature-sensitive drugs by regulatory bodies such as the U.S. FDA, the demand for cold storage has surged. Many vaccines, biologics, and gene therapies require precise temperature control to maintain their efficacy, thus driving the need for specialized GMP storage facilities.

Biotechnology Advancements: The increasing development of biologics, particularly in the fields of gene and cell therapies, has created a significant demand for GMP storage. These therapies require ultra-cold storage solutions to prevent degradation, further driving the need for advanced storage technologies.

Outsourcing of GMP Storage Services: Many biopharmaceutical companies are outsourcing GMP storage to avoid the high capital investment and operational costs associated with maintaining in-house storage facilities. This trend is helping to drive the demand for outsourced storage services, particularly for smaller biotech companies that do not have the resources to invest in such infrastructure.

Market Restraints

Despite the growth prospects, the GMP storage market faces several challenges:

High Capital Investment: Establishing and maintaining GMP storage facilities requires substantial capital investments, particularly for temperature-controlled facilities that require specialized refrigeration equipment. Additionally, the continuous operational costs, including energy consumption and regular maintenance, can be prohibitive for some companies.

Energy Costs: Maintaining temperature-sensitive products requires a constant supply of energy, and with rising energy costs globally, the operational costs of GMP storage facilities are increasing. This represents a significant challenge, especially for companies operating in regions with high electricity charges.

Complex Regulatory Compliance: GMP storage facilities must adhere to stringent regulatory requirements set by authorities like the U.S. FDA and the European Medicines Agency (EMA). These regulations are complex and can vary by country, making it difficult for companies to remain compliant in multiple markets.

Market Opportunities

The GMP storage market offers various growth opportunities, including:

Technological Advancements: The development of new storage technologies, such as energy-efficient refrigeration systems, controlled-rate freezers, and real-time monitoring systems, presents a significant opportunity for market growth. These innovations can help reduce the operational costs associated with GMP storage and improve the efficiency of the cold chain.

Expansion of Biopharmaceutical Manufacturing: The global rise in biopharmaceutical manufacturing, particularly in developing countries, offers substantial opportunities for GMP storage service providers. As the demand for biologics and gene therapies increases, there is a corresponding need for high-quality GMP storage solutions.

Emerging Markets: Countries in Asia-Pacific, Latin America, and Africa are expected to see increased demand for GMP storage services due to rising investments in the pharmaceutical and biopharmaceutical sectors. These emerging markets present lucrative growth opportunities for GMP storage providers.

Checkout Now & Download Complete Market Report: https://www.persistencemarketresearch.com/checkout/33113

Company Insights

Leading players in the GMP storage market are focusing on expanding their product portfolios, investing in research and development, and forming strategic partnerships to stay competitive. Key players in the market include:

• ThermoGenesis Holdings, Inc.
• ThermoFisher Scientific Inc.
• BioLife Solutions, Inc.
• Danaher (Cytiva)
• MEDIPOST
• REMI GROUP
• Eurofins Scientific
• Eppendorf
• Intertek Group Plc
• Arctiko
• Bioline Technologies
• Hindustan Apparatus Mfg. Co.
• P L Tandon & Co.
• Stericox India Private Limited
• SY-LAB Geräte GmbH
• BioConvergence LLC (Singota Solutions)
• PHC Holdings Corporation
• Pace Life Sciences
• Haier Biomedical
• Helmer Scientific Inc.

Key Segments Covered in GMP Storage Industry Research

GMP Storage Market by Product & Service:

GMP Storage Products
Refrigerators and Freezers
Cryogenic Storage
GMP Storage Services

GMP Storage Market by Application:

Cell & Gene Therapy
Cell Banking
Biologics
Small Molecules
Others

GMP Storage Market by End User:

Biopharmaceutical Companies
Contract Manufacturing Organizations
Contract Research Organizations
Research & Academic Institutes

GMP Storage Market by Region:

North America GMP Storage Market
Latin America GMP Storage Market
Europe GMP Storage Market
South Asia GMP Storage Market
East Asia GMP Storage Market
Oceania GMP Storage Market
The Middle East & Africa GMP Storage Market

Recent Developments:

BioLife Solutions acquired Global Cooling, Inc. in May 2021, expanding its portfolio of cold storage solutions.

BioLife Solutions introduced a high-capacity controlled-rate freezer line in April 2021 to support the growing demand for cell-based therapies.

Conclusion

The GMP storage market is set for substantial growth in the coming decade, driven by advancements in biotechnology, increasing demand for biologics, and the growing outsourcing trend within the pharmaceutical industry. Despite the challenges posed by high capital investments and regulatory complexities, the opportunities presented by technological advancements and the expansion of the biopharmaceutical sector provide significant potential for growth. With key players continuously innovating and expanding their product offerings, the GMP storage market is expected to reach a value of US$ 10.2 billion by 2032, positioning it as a critical segment within the global cold chain logistics industry.

Read More Related Reports:

Cold Laser Therapy Market https://www.persistencemarketresearch.com/market-research/cold-laser-therapy-market.asp
Lung Cancer Liquid Biopsy Market https://www.persistencemarketresearch.com/market-research/lung-cancer-liquid-biopsy-market.asp
Fecal Calprotectin Test Market https://www.persistencemarketresearch.com/market-research/fecal-calprotectin-test-market.asp
Guillain-Barre Syndrome Diagnostics Market https://www.persistencemarketresearch.com/market-research/guillain-barre-syndrome-diagnostics-market.asp

Contact Us:

Persistence Market Research
Second Floor, 150 Fleet Street, London, EC4A 2DQ, United Kingdom
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.